Hinge Health, Inc. Class A (HNGE) Price & Analysis

Compare

140 Followers

HNGE Stock Chart & Stats

$49.28

-$1.41(-3.71%)

At close: Jun 10 4:00 PM EDT

$49.28

-$1.41(-3.71%)

Day’s Range― - ―

52-Week Range$33.42 - $62.18

Previous Close$36.79

Volume525.07K

Average Volume (3M)1.16M

Market Cap

$3.98B

Enterprise Value$3.84B

Total Cash (Recent Filing)$413.26M

Total Debt (Recent Filing)$9.97M

Price to Earnings (P/E)27.7

Beta2.48

Next Earnings

Nov 04, 2025

EPS Estimate

0.23

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)0.35

Shares Outstanding27,223,448

10 Day Avg. Volume546,902

30 Day Avg. Volume1,163,023

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)N/A

Price to Sales (P/S)N/A

P/FCF RatioN/A

Enterprise Value/Market Cap0.96

Enterprise Value/Revenue14.60

Enterprise Value/Gross Profit19.39

Enterprise Value/Ebitda-6.85

Forecast

1Y Price Target

$61.91

Price Target Upside25.63% Upside

Rating ConsensusStrong Buy

Number of Analyst Covering14

Bulls Say, Bears Say

Bulls Say

AI And Technology ImpactAI innovations have materially improved Hinge Health’s MSK care platform, leading to improved clinical outcomes and increased member engagement.

Growth StrategyHinge's strong ROI, flexible pricing model and key payer/PBM relationships have created a value proposition that is resonating amongst benefits buyers in a rising healthcare cost environment.

Market LeadershipHinge Health app downloads were ~4x higher than the next largest competitor, reinforcing its strong leadership in MSK and providing a favorable read on one of the key debates for the stock regarding competition.

Bears Say

IPO Lock-up ExpirationAs sentiment shifted to negative over the course of the week, trepidation ahead of the IPO lock up expiration grew louder.

Hinge Health, Inc. Class A News

Hinge Health target raised, added to ‘Tactical Outperform’ list at Evercore ISI

Evercore ISI raised the firm’s price target on Hinge Health (HNGE) to $65 from $60 and keeps an...

11d ago

HNGE

Hinge Health price target raised to $67 from $57 at Morgan Stanley

Morgan Stanley raised the firm’s price target on Hinge Health (HNGE) to $67 from $57 and keeps an...

26d ago

HNGE

Hinge Health, Inc.: Strong Market Position and Growth Potential Justify Buy Rating

Analyst Craig Hettenbach of Morgan Stanley maintained a Buy rating on Hinge Health, Inc. Class A, retaining the...

6d ago

HNGE

Strong Buy Recommendation for Hinge Health, Inc. Amid Market Underestimation and Strategic Growth Potential

In a report released today, Craig Hettenbach from Morgan Stanley maintained a Buy rating on Hinge Health, Inc....

20d ago

HNGE

Hinge Health: Strong Buy Rating Driven by AI Innovation and Operational Efficiency

Morgan Stanley analyst Craig Hettenbach has maintained their bullish stance on HNGE stock, giving a Buy rating on...

26d ago

HNGE

Hinge Health price target raised to $66 from $63 at Stifel

Stifel analyst David Grossman raised the firm’s price target on Hinge Health (HNGE) to $66 from $63 and...

1M ago

HNGE

Hinge Health initiated with a Neutral at Baird

Baird analyst Vikram Kesavabhotla last night initiated coverage of Hinge Health (HNGE) with a Neutral rating and $56...

1M ago

HNGE

Hinge Health initiated with a Neutral at Baird

Baird analyst Vikram Kesavabhotla initiated coverage of Hinge Health (HNGE) with a Neutral rating and $56 price target...

1M ago

HNGE

Hinge Health falls -8.5%

Hinge Health (HNGE) is down -8.5%, or -$5.03 to $54.00. Published first on TheFly – the ultimate source...

2M ago

HNGE

Hinge Health’s Strategic Initiatives and Growth Potential Drive Buy Rating

Canaccord Genuity analyst Richard Close maintained a Buy rating on Hinge Health, Inc. Class A yesterday and set...

2M ago

HNGE

Hinge Health Announces Early Share Lock-Up Release

Hinge Health, Inc. Class A ( ($HNGE) ) just unveiled an announcement. Hinge Health, Inc. recently completed its...

2M ago

HNGE

Hinge Health’s Strategic Growth and Market Positioning: A Buy Recommendation by Ryan MacDonald

Needham analyst Ryan MacDonald maintained a Buy rating on Hinge Health, Inc. Class A today and set a...

2M ago

HNGE

Hinge Health’s Strong Growth and Margin Improvements Drive Buy Rating and Increased Price Objective

Analyst Bradley Sills of Bank of America Securities reiterated a Buy rating on Hinge Health, Inc. Class A,...

2M ago

HNGE

Hinge Health price target raised to $65 from $45 at Raymond James

Raymond James raised the firm’s price target on Hinge Health (HNGE) to $65 from $45 and keeps an...

2M ago

HNGE

HNGE FAQ

What was Hinge Health, Inc. Class A’s price range in the past 12 months?

Hinge Health, Inc. Class A lowest stock price was $33.42 and its highest was $62.18 in the past 12 months.

What is Hinge Health, Inc. Class A’s market cap?

Hinge Health, Inc. Class A’s market cap is $3.98B.

When is Hinge Health, Inc. Class A’s upcoming earnings report date?

Hinge Health, Inc. Class A’s upcoming earnings report date is Nov 04, 2025 which is in 16 days.

How were Hinge Health, Inc. Class A’s earnings last quarter?

Hinge Health, Inc. Class A released its earnings results on Aug 05, 2025. The company reported $0.349 earnings per share for the quarter, beating the consensus estimate of $0.086 by $0.263.

Is Hinge Health, Inc. Class A overvalued?

According to Wall Street analysts Hinge Health, Inc. Class A’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does Hinge Health, Inc. Class A pay dividends?

Hinge Health, Inc. Class A does not currently pay dividends.

What is Hinge Health, Inc. Class A’s EPS estimate?

Hinge Health, Inc. Class A’s EPS estimate is 0.23.

How many shares outstanding does Hinge Health, Inc. Class A have?

Hinge Health, Inc. Class A has 27,223,448 shares outstanding.

What happened to Hinge Health, Inc. Class A’s price movement after its last earnings report?

Hinge Health, Inc. Class A reported an EPS of $0.349 in its last earnings report, beating expectations of $0.086. Following the earnings report the stock price went up 25.57%.

Which hedge fund is a major shareholder of Hinge Health, Inc. Class A?

Currently, no hedge funds are holding shares in HNGE

Hinge Health, Inc. Class A Stock Smart Score

Neutral

Company Description

Hinge Health, Inc. Class A

Hinge Health, Inc. develops health care software for joint and muscle health. The company designs its platform to address a musculoskeletal care, acute injury, chronic pain, and post-surgical rehabilitation. It also provides various administrative and operations support services. The company was founded in 2012 and is headquartered in San Francisco, California.

Hinge Health, Inc. Class A (HNGE) Earnings & Revenues

Historic Earnings Reports

HNGE Company Deck

HNGE Earnings Call

Q2 2025

0:00 / 0:00

HNGE Stock 12 Month Forecast

Average Price Target

$61.91

▲(25.63% Upside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"39":"$39","47":"$47","55":"$55","63":"$63","71":"$71"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":70,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$70.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":61.91,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$61.91</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":51,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$51.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[39,47,55,63,71],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Feb<br/>2025","6":"May<br/>2025","9":"Jul<br/>2025","12":"Oct<br/>2025","25":"Oct<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,48.75,50.38461538461539,52.01923076923077,53.65384615384615,55.28846153846154,56.92307692307692,58.55769230769231,60.19230769230769,61.82692307692308,63.46153846153846,65.09615384615384,66.73076923076923,68.36538461538461,{"y":70,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,48.75,49.762307692307694,50.77461538461539,51.786923076923074,52.79923076923077,53.81153846153846,54.823846153846155,55.83615384615385,56.848461538461535,57.86076923076923,58.87307692307692,59.88538461538461,60.89769230769231,{"y":61.91,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,48.75,48.92307692307692,49.09615384615385,49.26923076923077,49.44230769230769,49.61538461538461,49.78846153846154,49.96153846153846,50.13461538461539,50.30769230769231,50.48076923076923,50.65384615384615,50.82692307692308,{"y":51,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":40.16,"date":1730419200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":40.16,"date":1733011200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":40.16,"date":1735689600000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":40.16,"date":1738368000000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":40.16,"date":1740787200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":40.16,"date":1743465600000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":40.16,"date":1746057600000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":40.45,"date":1748736000000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":40.45,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":45.31,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":44.95,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 32,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":55.68,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 23,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":48.75,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 23,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >